Identification of genes preferentially expressed in the pathogenic yeast phase of Paracoccidioides brasiliensis,

E R Marques1, M E S Ferreira, R D Drummond

  • 1Departamento de Ciências Farmacêuticas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Av. do Café S/N, CEP 14040-903, Ribeirão Preto, São Paulo, Brazil.

Insights

Paracoccidioides brasiliensis yeast cells express specific genes crucial for pathogenicity. Identifying these genes aids in understanding and combating paracoccidioidomycosis (PCM), a significant fungal infection.

Area of Science:

  • Mycology
  • Medical Mycology
  • Molecular Biology

Background:

  • Paracoccidioides brasiliensis causes paracoccidioidomycosis (PCM), a prevalent systemic mycosis in Latin America.
  • Pathogenicity is linked to the fungus's dimorphic transition from hyphal to yeast form, triggered by host temperature.
  • Limited knowledge exists regarding P. brasiliensis genes essential for its pathogenic yeast phase.

Purpose of the Study:

  • To identify genes preferentially expressed in the yeast phase of P. brasiliensis.
  • To understand the molecular basis of fungal pathogenicity during the yeast form.

Main Methods:

  • Suppression Subtraction Hybridization (SSH) and macroarray analyses were employed to identify differentially expressed genes.
  • Real-time RT-PCR experiments validated gene expression levels under various culture conditions (temperature and media).

Main Results:

  • SSH and macroarray analyses revealed genes involved in metabolism, signal transduction, growth, morphogenesis, and sulfur metabolism are upregulated in the yeast phase.
  • Twenty genes, including AGS1 and TSA1, were confirmed to be more highly expressed in yeast cells compared to hyphae via RT-PCR.
  • A general trend of increased gene expression in the yeast form was observed, irrespective of media richness.

Conclusions:

  • The study identified key genes upregulated in the pathogenic yeast form of P. brasiliensis.
  • These findings contribute to understanding the molecular mechanisms underlying fungal dimorphism and pathogenicity.
  • The identified genes represent potential targets for future therapeutic strategies against PCM.